Maximum FDA Warnings For Indian Pharma Firms This Year For Selling Unapproved Medicines
Posted by
www.biotecnika.org
FDA warned Indian Pharma Firms for Misbranding and Selling Unapproved
Medicines. Indian pharma companies received 34% of the warnings from
the United States Food and Drug Administration (FDA) issued for
misbranding, selling unapproved medicines as well as for violating
Current Good Management Practices so far this year. FDA issued 38
warning letters to pharmaceutical companies […]
The post Maximum FDA Warnings For Indian Pharma Firms This Year For
Selling Unapproved Medicines appeared first on Rasayanika .
https://www.rasayanika.com/2019/08/22/fda-warned-indian-pharma-firms-is-historically-high-for-misbranding/
News
Subscribe to:
Post Comments (Atom)
Post a Comment